2020
Cancer cure for 32 cancer types: results from the EUROCARE-5 study
Dal Maso L, Panato C, Tavilla A, Guzzinati S, Serraino D, Mallone S, Botta L, Boussari O, Capocaccia R, Colonna M, Crocetti E, Dumas A, Dyba T, Franceschi S, Gatta G, Gigli A, Giusti F, Jooste V, Minicozzi P, Neamtiu L, Romain G, Zorzi M, De Angelis R, Francisci S, Group T. Cancer cure for 32 cancer types: results from the EUROCARE-5 study. International Journal Of Epidemiology 2020, 49: 1517-1525. PMID: 32984907, DOI: 10.1093/ije/dyaa128.Peer-Reviewed Original ResearchConceptsConditional relative survivalCancer patientsProstate cancerCancer cureChronic lymphocytic leukemia patientsProportion of patientsThyroid cancer patientsEUROCARE-5 studyLymphocytic leukemia patientsSame death ratePopulation-based indicatorsMelanoma patientsPatients' qualityCorpus uteriFatal casesLung cancerPancreatic cancerThyroid cancerLeukemia patientsBreast cancerGeneral populationRelative survivalPatientsSkin melanomaAge 55
2019
Net survival in recurrence-free colon cancer patients
Drouillard A, Bouvier A, Boussari O, Romain G, Manfredi S, Lepage C, Faivre J, Jooste V. Net survival in recurrence-free colon cancer patients. Cancer Epidemiology 2019, 61: 124-128. PMID: 31212224, DOI: 10.1016/j.canep.2019.06.001.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedColonic NeoplasmsFemaleHumansMaleMiddle AgedPrognosisQuality of LifeSurvival AnalysisSurvivorsConceptsRecurrence-free patientsNet survivalColon cancerPopulation-based digestive cancer registryConditional net survivalDigestive cancer registryStage III diseasePeriods of remissionEstimation of prognosisPrimary colon cancerColon cancer patientsRelevant clinical informationCancer RegistryClinical presentationCancer patientsCancer populationSurvivors' qualityClinical informationPatientsStage IStage IIIStage IIDiagnosisFlexible parametric modelsSurvival